C. Sessa

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.

A. Goldhirsch, B. Thürlimann, D. Crivellari, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Advanced epithelial ovarian cancer: 1998 consensus statements.

J. Neijt, G. Rustin, J. Berek, 1993 .

5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.

R. Stupp, R. Herrmann, A. Goldhirsch, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

J. Douillard, E. Cutsem, K. Fumasoli, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial

D. Matei, M. Einstein, F. Haluska, 2013, British Journal of Cancer.

Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).

F. Cavalli, M. van Glabbeke, M. Glabbeke, 1988, European journal of cancer & clinical oncology.

Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group.

S. Aamdal, J. Wanders, C. Sessa, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.